価格表

在庫・価格 : 2024年06月25日 02時22分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TLR3, Mouse-Mono(40C1285.6), PE
データシート
NBP2-24902 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥115,000
(未発注)
追加

在庫・価格 : 2024年06月25日 02時22分 現在

Anti-TLR3, Mouse-Mono(40C1285.6), PE

  • 商品コード:NBP2-24902
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥115,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fran巽ois S et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 2005 Mar;
Fran巽ois S et al
2005/01/01
Applications: PubMed
2 Dasgupta G et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest. Ophthalmol. Vis. Sci. 2011 May;52(6):3321-33
Dasgupta G et al
2011/01/01
Applications: PubMed
3 Johnston MJ et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect. Immun. 2010 Mar;78(3):1364-75
Johnston MJ et al
2010/01/01
Applications: PubMed
4 Østvik AE et al. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin. Exp. Immunol. 2013 Sep;173(3):502-11
Østvik AE et al
2013/01/01
Applications: PubMed
5 Cohen PA et al. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 2008 Sep;112(5):1832-43
Cohen PA et al
2008/01/01
Applications: PubMed
6 Yan K et al. Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells. Mol. Cell. Endocrinol. 2013 Jun;372(1-2):73-85
Yan K et al
2013/01/01
Applications: PubMed
7 Xu S et al. High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production. Surgery 2006 Aug;140(2):170-8
Xu S et al
2006/01/01
Applications: PubMed
8 Pohar J et al. The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. J. Biol. Chem. 2013 Jan;288(1):442-54
Pohar J et al
2013/01/01
Applications: PubMed
9 Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
Wong CK et al
2007/01/01
Applications: PubMed
10 Mansson A et al. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006;7:36
Mansson A et al
2006/01/01
Species: Human, Applications: Flow-IC PubMed
11 Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
Burgener IA et al
2008/01/01
Applications: PubMed
12 Funami K et al. The cytoplasmic "linker region" in Toll-like receptor 3 controls receptor localization and signaling. Int. Immunol. 2004 Aug;16(8):1143-54
Funami K et al
2004/01/01
Applications: PubMed
13 Abdi J et al. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE 2013;8(4):e60671
Abdi J et al
2013/01/01
PubMed
14 Yamashita M et al. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal 2012 Jul;5(233):ra50
Yamashita M et al
2012/01/01
PubMed
15 M辿nager P et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 2009 Feb;5(2):e1000315
M辿nager P et al
2009/01/01
PubMed
16 Ranjith-Kumar CT et al. Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J. Biol. Chem. 2007 Mar;282(10):7668-78
Ranjith-Kumar CT et al
2007/01/01
Applications: WB PubMed
17 Sacre SM et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J. Immunol. 2008 Dec;181(11):8002-9
Sacre SM et al
2008/01/01
PubMed
18 Kuznik A et al. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J. Immunol. 2011 Apr;186(8):4794-804
Kuznik A et al
2011/01/01
PubMed
19 Kleinman ME et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol. Ther. 2012 Jan;20(1):101-8
Kleinman ME et al
2012/01/01
PubMed
20 Tengroth L et al. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS ONE 2014;9(8):e105618
Tengroth L et al
2014/01/01
Species: Human, Applications: FLOW PubMed
21 Green TL et al. Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp. Mol. Pathol. 2014 Aug;97(1):44-8
Green TL et al
2014/01/01
Species: Human, Applications: Flow-IC PubMed
22 Jamin A et al. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin. Exp. Immunol. 2015 Dec;182(3):332-45
Jamin A et al
2015/01/01
Species: Human, Applications: FLOW PubMed
23 Evangelista MG et al. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 2016 Jun;49(4):258-67
Evangelista MG et al
2016/01/01
PubMed
24 Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
Larsson O et al
2018/01/01
Species: Mouse, Applications: Flow PubMed
  • No.: 1
  • 文献情報:
    Fran巽ois S et al. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J. Immunol. 2005 Mar;
    Fran巽ois S et al
    2005/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Dasgupta G et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest. Ophthalmol. Vis. Sci. 2011 May;52(6):3321-33
    Dasgupta G et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Johnston MJ et al. Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect. Immun. 2010 Mar;78(3):1364-75
    Johnston MJ et al
    2010/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Østvik AE et al. Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2. Clin. Exp. Immunol. 2013 Sep;173(3):502-11
    Østvik AE et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Cohen PA et al. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood 2008 Sep;112(5):1832-43
    Cohen PA et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Yan K et al. Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells. Mol. Cell. Endocrinol. 2013 Jun;372(1-2):73-85
    Yan K et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Xu S et al. High-avidity antitumor T-cell generation by toll receptor 8-primed, myeloid- derived dendritic cells is mediated by IL-12 production. Surgery 2006 Aug;140(2):170-8
    Xu S et al
    2006/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Pohar J et al. The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. J. Biol. Chem. 2013 Jan;288(1):442-54
    Pohar J et al
    2013/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Wong CK et al. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am. J. Respir. Cell Mol. Biol. 2007 Jul;37(1):85-96
    Wong CK et al
    2007/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Mansson A et al. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir. Res. 2006;7:36
    Mansson A et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Flow-IC
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Burgener IA et al. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet. Immunol. Immunopathol. 2008 Jul;124(1-2):184-91
    Burgener IA et al
    2008/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Funami K et al. The cytoplasmic "linker region" in Toll-like receptor 3 controls receptor localization and signaling. Int. Immunol. 2004 Aug;16(8):1143-54
    Funami K et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Abdi J et al. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE 2013;8(4):e60671
    Abdi J et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Yamashita M et al. Epidermal growth factor receptor is essential for Toll-like receptor 3 signaling. Sci Signal 2012 Jul;5(233):ra50
    Yamashita M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    M辿nager P et al. Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. PLoS Pathog. 2009 Feb;5(2):e1000315
    M辿nager P et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Ranjith-Kumar CT et al. Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J. Biol. Chem. 2007 Mar;282(10):7668-78
    Ranjith-Kumar CT et al
    2007/01/01
  • 備考:
    Applications: WB
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Sacre SM et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J. Immunol. 2008 Dec;181(11):8002-9
    Sacre SM et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Kuznik A et al. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J. Immunol. 2011 Apr;186(8):4794-804
    Kuznik A et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kleinman ME et al. Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol. Ther. 2012 Jan;20(1):101-8
    Kleinman ME et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Tengroth L et al. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS ONE 2014;9(8):e105618
    Tengroth L et al
    2014/01/01
  • 備考:
    Species: Human, Applications: FLOW
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Green TL et al. Toll-like receptor (TLR) expression of immune system cells from metastatic breast cancer patients with circulating tumor cells. Exp. Mol. Pathol. 2014 Aug;97(1):44-8
    Green TL et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Flow-IC
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Jamin A et al. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin. Exp. Immunol. 2015 Dec;182(3):332-45
    Jamin A et al
    2015/01/01
  • 備考:
    Species: Human, Applications: FLOW
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Evangelista MG et al. Early IFN-γ production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity 2016 Jun;49(4):258-67
    Evangelista MG et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Larsson O et al. Substance P represents a novel first-line defense mechanism in the nose. J. Allergy Clin. Immunol. 2018 Jan;141(1):128-136.e3
    Larsson O et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: Flow
  • 参照:
    PubMed